| 1 day | -16.59% |
| Manager | Title | Age | Since |
|---|---|---|---|
Carl Merton
CEO | Chief Executive Officer | 57 | 22/06/2023 |
Pamela McRae
CTO | Chief Tech/Sci/R&D Officer | - | - |
Richard Redekop
COO | Chief Operating Officer | - | 15/06/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Vincent Chiara
BRD | Director/Board Member | - | 04/11/2016 |
Peter Montour
BRD | Director/Board Member | - | 30/08/2021 |
William Montour
BRD | Director/Board Member | - | 05/01/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02/05/23 | Other | Director | 0 | 0% | ||
| 28/04/23 | Option | Director | 26,864 | 0.0626% | ||
| 28/04/23 | Tax | Director | 1,38,032 | 0.3215% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -16.59% | -39.87% | - | - | 2.94Cr | ||
| +0.15% | -2.67% | +219.71% | -4.58% | 248.34Cr | ||
| +4.52% | +1.97% | +116.40% | +103.47% | 169.04Cr | ||
| 0.00% | -2.49% | -24.97% | +128.83% | 45Cr | ||
| 0.00% | -4.92% | +16.00% | +16.00% | 6.32Cr | ||
| Average | -2.38% | -1.63% | +81.78% | +60.93% | 117.23Cr | |
| Weighted average by Cap. | +1.59% | -0.99% | +156.13% | +47.51% |
Employees
-
Sector
Pharmaceuticals
















